Heat-Activated Viral Vector Gene Switch for Controlled Replication

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gene delivery technologies, such as viral and non-viral vectors, lack specific control over gene expression and replication, particularly in targeted tissues, due to uncertainties with tissue-specific promoters and difficulties in achieving intermediate levels of gene activity and localized regulation.

Innovation Solution

Development of a modified, conditionally replicating virus with a gene switch that is activated by a combination of heat and a small-molecule regulator, allowing for precise control of viral replication and passenger gene expression, using a mechanism not inherently present in wildtype viruses, specifically utilizing a transactivator gene linked to a heat shock promoter and a transactivator-responsive promoter.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If tissue-specific promoters are used to restrict virus replication or gene expression to specific cell types, then some level of tissue-specificity is achieved, but the control is uncertain and may display activity in unintended cells

Engineering Contradiction:
Improvespecificity of gene expression controlVSAvoidprecision of spatial control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The system divides control into two independent modules: a heat-activatable promoter provides spatial control while a small-molecule-regulated gene switch provides temporal control. This segmentation allows each module to optimize one aspect of control without compromising the other, achieving both high specificity and precision.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces heat as an intermediary physical stimulus that activates the promoter without being a chemical substance that diffuses through tissues. This intermediary approach enables precise spatial control through localized heating while avoiding the diffusion problem of small-molecule regulators.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If small-molecule regulators are used to control gene switches, then stringent on-off regulation can be achieved, but basal gene activity cannot be controlled and intermediate levels are difficult to achieve

Engineering Contradiction:
Improvestringency of on-off regulationVSAvoidability to control intermediate gene activity levels
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system enables dynamic control of gene expression by combining heat activation with small-molecule regulation. The heat-activatable promoter provides a baseline 'on' state, while the small-molecule-regulated switch allows fine-tuning of expression levels, enabling both stringent on-off control and intermediate expression levels through variable small-molecule concentrations.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent utilizes parameter changes in small-molecule concentration to control intermediate gene expression levels. By varying the concentration of the small-molecule regulator, the system can achieve a spectrum of expression levels from fully off to fully on, providing precise ease of operation while maintaining regulatory stringency.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If heat-activated promoters are used to restrict gene expression to target tissues, then localized control is achieved, but inadvertent activation can occur during fever, ischemia/reperfusion, exercise, or exposure to oxidant stress

Engineering Contradiction:
Improveprecision of localized gene expressionVSAvoidunintended activation during physiological stress
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent merges two control mechanisms: heat activation and small-molecule regulation. Both conditions must be satisfied simultaneously for gene expression to occur. This combination resolves the reliability issue because physiological stressors like fever or exercise alone cannot activate the system without the corresponding small-molecule regulator being present, while still maintaining the precision of localized control through heat.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The system requires preliminary action of both heat activation and small-molecule addition to enable gene expression. This dual preliminary requirement ensures that inadvertent activation during physiological stress does not occur, as the small-molecule regulator would not be present during natural stress events, while still allowing precise localized control when both conditions are intentionally provided.

Inventive Principle:
Principle #10Preliminary action

4Reliability

If a gene switch controlled by both heat and small-molecule regulator is used, then safe spatial and temporal control is achieved, but the device complexity increases

Engineering Contradiction:
Improvesafety of controlled gene expressionVSAvoidcomplexity of dual-controlled gene switch
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The complex control system is segmented into two independent, well-established modules: a heat-activatable promoter module and a small-molecule-regulated gene switch module. Each module can be independently optimized and characterized, reducing the overall complexity compared to designing a completely new single-module system while achieving enhanced safety through dual control.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables stringent, spatial, and temporal control of gene expression and virus replication, minimizing unintended activation and ensuring targeted gene therapy applications, including localized therapy and tumor treatment.

Implementation Method 1

a gene switch that is activated by heat in the presence or absence of a small-molecule regulator

Methodology Applied
Scientific EffectHeat shock promoter activation: Heat Treatment

Implementation Method 2

controlled by a gene switch that is dually controlled by heat and a small-molecule regulator

Methodology Applied
Scientific EffectMolecular binding and regulation:

Data Source

PatentUS7906312B2Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
Publication Date: 2011.03.15 VOELLMY RICHARD
  • US7906312B2 patent drawing
  • US7906312B2 patent drawing
  • US7906312B2 patent drawing

AI summary

The present invention relates to conditionally replicating viruses or pairs of viruses containing a gene switch that is activatable by transient heat or other proteotoxic stress in the presence or absence of a small molecule regulator. The gene switch controls the expression of a gene for a protein required for efficient viral replication and may also control the activity of a passenger gene.